Gent, Belgium and Perth, Australia
November 21, 2000
CropDesign N.V. (CropDesign) and
Grain Biotech Australia Pty
Ltd (GBA) announced today that they have signed an agreement
for a joint wheat product development program for Australia. The
alliance is designed to accelerate introduction of CropDesign’s
yield enhancement technologies into commercial wheat varieties for Australia and elsewhere. Under the terms of the agreement,
CropDesign and GBA will make certain of their technologies and wheat germplasm available to the program. The alliance has
exclusive rights to the program for Australia, while CropDesign
has exclusive rights outside of Australia. CropDesign and GBA will share royalties from any wheat varieties developed by the
alliance and which are licensed internationally. CropDesign also
has the exclusive right outside of Australia to use wheat germplasm from the program containing its technology for
backcrossing. Backcrossing is a plant breeding method commonly used to transfer valuable traits between varieties.
Research under the new alliance has already commenced at GBA’s laboratories.
CropDesign employs several growth and development technologies, including cell cycle and other plant genes, to develop products such as
higher yielding and hardier varieties of wheat, rice and other cereals.
Earlier this year CropDesign was issued a broad U.S. patent, based on
an invention of Dr. Pete John at the Australian National University in
Canberra, covering plant cell cycle technology. Cell cycle is the process
of cell division and cell growth, and is fundamental to all plants and
animals. Changes in cell cycle can effect plant cell growth and cell size,
as well as plant maturity, shape and general health. By modulating cell
cycle and other genes, CropDesign and GBA intend to develop hardier
and high yielding wheat varieties adapted for specific environmental
requirements. Access to the results of the TraitMill™, CropDesign’s
plant evaluation system for high-throughput evaluation of genes for crop
improvement, is a key part of the agreement.
According to Dr. Herman Van Mellaert, CropDesign CEO, the alliance
with GBA will help validate the company’s strategy and technologies for
cereal yield enhancement and stress tolerance under actual field
conditions. "This agreement with GBA leverages our gene discovery
and function research further into product development. It is also the
first of a number of partnering opportunities to make use of the
TraitMill™ for rapid evaluation of crop improvement genes". Van
Mellaert added, "Moving CropDesign’s technology from the laboratory
to the wheat field is necessary to confirm its potential for value creation
at the farm gate. This agreement gives us a head-start in developing
higher yielding wheat and other cereals for Australia and the rest of the
world. With GBA’s expertise in wheat germplasm development and
biotechnology, we have an ideal partner for our functional genomics
research in this important crop". Wheat is the most important food crop
worldwide.
Dr. Ian Edwards, CEO of Grain Biotech Australia said: "This agreement
provides excellent synergies by bringing together our expertise in
molecular biology and wheat breeding with CropDesign’s world-class
functional genomics resources. In Australia we face a number of abiotic
or environmental stresses that limit wheat production, and we believe
that the cell cycle genes will constitute an important addition to our
portfolio of novel genes. Sustainable competitiveness in wheat development requires precisely the combination of strengths in
functional genomics, high-throughput gene evaluation, biotechnology
and modern plant breeding that we expect to achieve with this agreement". Dr. Edwards, former Worldwide Director of Field Crops
Research for Pioneer Hi-Bred International, Inc. has 35 years of
international experience in wheat breeding and variety and hybrid
development. Dr. Edwards added, "GBA is committed to ensuring that
Australia’s wheat producers and end users have access to leading
technologies that will not only enhance yield but ensure the country’s
competitiveness in the global wheat market".
CropDesign, based in Gent, Belgium is an agbiotech company focussed
on the application of functional genomics for improved crop performance, including higher yield, heightened tolerance to stress and
diseases and better quality. CropDesign applies its technology in rice,
wheat and other cereals. Founded in 1998, CropDesign employs over
60 people at its research facilities in Gent.
Grain Biotech Australia is headquartered in Perth, Western Australia. It
is the country’s first private company to combine biotechnology with
applied plant breeding to produce wheat varieties with added value for
producers, processors and consumers. The company was founded in
1999 with strong grower support, including the Council of Grain Grower
Organizations and the Export Grain Centre. GBA conducts the largest
Australian private wheat research and development program.
Company news release
N2839b |